Display options
Cite
Ryffel B. Summary and Overview of Safety Considerations. Clin Immunol Immunopathol. 1997;83(1):31doi: 10.1006/clin.1996.4309.
Ryffel, B. (1997). Summary and Overview of Safety Considerations. Clinical immunology and immunopathology, 83(1), 31. https://doi.org/10.1006/clin.1996.4309
Ryffel. "Summary and Overview of Safety Considerations." Clinical immunology and immunopathology vol. 83,1 (1997): 31. doi: https://doi.org/10.1006/clin.1996.4309
Ryffel B. Summary and Overview of Safety Considerations. Clin Immunol Immunopathol. 1997 Apr;83(1):31. doi: 10.1006/clin.1996.4309. PMID: 9073532.
Copy Download .nbib Format: NLM
Share it on

Clin Immunol Immunopathol. 1997 Apr;83(1):31. doi: 10.1006/clin.1996.4309.

Summary and Overview of Safety Considerations.

Clinical immunology and immunopathology

Ryffel

Affiliations

  1. Institute of Pathology, Schonbeinstrasse 40, Basel, CH-4031, Switzerland

PMID: 9073532 DOI: 10.1006/clin.1996.4309

[No abstract available.]

Publication Types